{
    "clinical_study": {
        "@rank": "28323", 
        "arm_group": {
            "arm_group_label": "Formoterol", 
            "description": "12 mcg BID for four weeks"
        }, 
        "biospec_descr": {
            "textblock": "white cells"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Polymorphism at codon 16 of the beta2-adrenoceptor (beta2-AR) affects the responsiveness to\n      salmeterol in asthmatics. Data concerning formoterol are more controversial in literature.\n      The aim of this study was to verify whether  homozygote for arginine-16 (ArgArg16) and\n      homozygote for glycine-16 (GlyGly16) genotypes differently influence the long-term\n      responsiveness to formoterol."
        }, 
        "brief_title": "Polymorphism of beta2-adrenoceptor and Regular Use of Formoterol in Asthma", 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Mild to moderate asthma\n\n          -  Stable clinical conditions\n\n        Exclusion Criteria:\n\n          -  Smokers\n\n          -  Current therapy with oral steroids\n\n          -  Exacerbations within the past 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Pneumological outpatient clinic"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01786616", 
            "org_study_id": "UCSC-AG-16"
        }, 
        "intervention": {
            "arm_group_label": "Formoterol", 
            "intervention_name": "Formoterol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Formoterol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "zip": "00168"
                }, 
                "name": "Catholic University, Pneumology Unit"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Polymorphism of beta2-adrenoceptor and Regular Use of Formoterol in Asthma: Preliminary Results", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Peak Expiratory Flow (PEF) variability", 
            "safety_issue": "No", 
            "time_frame": "PEF has been monitorized during the 4-week treatment period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01786616"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Catholic University, Italy", 
            "investigator_full_name": "Leonello Fuso", 
            "investigator_title": "Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Forced Expiratory Volume in 1 sec (FEV1) slope of the dose-response curve to salbutamol", 
            "safety_issue": "No", 
            "time_frame": "At the end of the 4-week treatment period"
        }, 
        "source": "Catholic University, Italy", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Catholic University, Italy", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2005", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}